Skip to main content
news
The logo of Itochu Corp is seen outside the company's headquarters in Tokyo, Japan, November 7, 2016. REUTERS/Toru Hanai

 

Nagashima Ohno & Tsunematsu is advising Japanese trading house Itochu Corp on its 182.6-billion-yen ($1.24 billion) offer to take full control of sportswear maker Descente, which is being represented by Mori Hamada & Matsumoto.

Anderson Mori & Tomotsune is counselling the special committee set up by Descente, which has licensed brands such as Le Coq Sportif, Munsingwear and Umbro and is heavily focused on the South Korean market, to assess Itochu’s takeover bid.

According to Reuters, Itochu has amassed a 40 percent stake in Descente, setting the stage for a rare hostile takeover in Japan's consensus-driven market.

A stake of more than one-third gives Itochu veto power over acquisitions and other strategic decisions, Reuters added, noting that the company will also have a greater say in nominating Descente's board members.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

N&A, S&C, TMI advise as Japan's Nidec makes $1.6 bln bid for Makino Milling

TMI Associates, Freshfields and Davis Polk & Wardwell have represented Japanese manufacturing giant Nidec on its 257-billion-yen ($1.6 billion) bid for Makino Milling Machine, which turned to Nishimura & Asahi and Sullivan & Cromwell for advice.

N&A, MHM, Skadden, STB guide JX Advanced Metal’s $3 bln Japan IPO

by Nimitt Dixit |

Nishimura & Asahi and Skadden Arps Slate Meagher & Flom are advising JX Advanced Metals on its upcoming 460-billion-yen ($3 billion) initial public offering, the largest listing in Japan since SoftBank Corp’s $23.5 billion IPO in 2018.

Trilegal, Touchstone, CAM act on Carlyle’s $400 mln entry into India auto-components space

by Nimitt Dixit |

Trilegal has advised global private equity firm Carlyle on its acquisition of majority stakes in Highway Industries (HIL) and Roop Automotives for $400 million, marking its entry into India's auto components sector through a new manufacturing platform.